Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Carducci

Showing results (41-50 of 452) with videos related to

Pageof 46
Sort By:
Cancer Journal (Sudbury, Mass.)|January 23, 2013
From bevacizumab to tasquinimod: angiogenesis as a therapeutic target in prostate cancerMichael T Schweizer, Michael A Carducci
Cancer Treatment Reviews|October 11, 2016
Early use of chemotherapy in metastatic prostate cancerMark C Markowski, Michael A Carducci
European Journal of Epidemiology|September 1, 1990
Serum antibodies to polioviruses in a Tuscan population, ItalyD Reali, A Carducci, M A Ruschi
Epidemiology and Infection|June 1, 1989
Cost-benefit analysis of tetanus prophylaxis by a mathematical modelA Carducci, C M Avio, M Bendinelli
Current Cancer Drug Targets|December 23, 2009
HIF-1alpha and calcium signaling as targets for treatment of prostate cancer by cardiac glycosidesJ Lin, S Denmeade, M A Carducci
Prostate Cancer and Prostatic Diseases|April 26, 2017
A review of pomegranate in prostate cancerC J Paller, A Pantuck, M A Carducci
Italian Journal of Gastroenterology and Hepatology|March 17, 1999
New acquisitions in Helicobacter pylori characteristicsN Figura, C Vindigni, L Presenti, et al.
Asian Journal of Andrology|January 11, 2012
Use of androgen deprivation therapy in prostate cancer: indications and prevalenceRoisin M Connolly, Michael A Carducci, Emmanuel S Antonarakis
Bollettino Della Societa Italiana Di Biologia Sperimentale|December 30, 1975
[Effects of adrenergic blocking agents on HGH secretion after administration of L-Dopa]F Ragonese, K Melluso, R Campisi, et al.
The Journal of Urology|November 7, 2006
Recommendations for defining and treating high risk localized prostate cancerIan M Thompson, Peter R Carroll, Michael A Carducci
Pageof 46

Showing results (41-50 of 452) with videos related to

Sort By:
Pageof 46
Cancer Journal (Sudbury, Mass.)|January 23, 2013
From bevacizumab to tasquinimod: angiogenesis as a therapeutic target in prostate cancerMichael T Schweizer, Michael A Carducci
Cancer Treatment Reviews|October 11, 2016
Early use of chemotherapy in metastatic prostate cancerMark C Markowski, Michael A Carducci
European Journal of Epidemiology|September 1, 1990
Serum antibodies to polioviruses in a Tuscan population, ItalyD Reali, A Carducci, M A Ruschi
Epidemiology and Infection|June 1, 1989
Cost-benefit analysis of tetanus prophylaxis by a mathematical modelA Carducci, C M Avio, M Bendinelli
Current Cancer Drug Targets|December 23, 2009
HIF-1alpha and calcium signaling as targets for treatment of prostate cancer by cardiac glycosidesJ Lin, S Denmeade, M A Carducci
Prostate Cancer and Prostatic Diseases|April 26, 2017
A review of pomegranate in prostate cancerC J Paller, A Pantuck, M A Carducci
Italian Journal of Gastroenterology and Hepatology|March 17, 1999
New acquisitions in Helicobacter pylori characteristicsN Figura, C Vindigni, L Presenti, et al.
Asian Journal of Andrology|January 11, 2012
Use of androgen deprivation therapy in prostate cancer: indications and prevalenceRoisin M Connolly, Michael A Carducci, Emmanuel S Antonarakis
Bollettino Della Societa Italiana Di Biologia Sperimentale|December 30, 1975
[Effects of adrenergic blocking agents on HGH secretion after administration of L-Dopa]F Ragonese, K Melluso, R Campisi, et al.
The Journal of Urology|November 7, 2006
Recommendations for defining and treating high risk localized prostate cancerIan M Thompson, Peter R Carroll, Michael A Carducci
Pageof 46